The bayesian analysis of population pharmacokinetic models

Journal of the American Statistical Association

Volumn 91, Issue 433, 1996, Pages 62-75

  Wakefield, Jon ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Covariate selection; Hastings Metropolis algorithm; Hierarchical models; Pharmacokinetic models

Indexed keywords

EID: 0001880068     PISSN: 01621459     EISSN: 1537274X     Source Type: Journal    
DOI: 10.1080/01621459.1996.10476664     Document Type: Article

References (46)

1. Aarons, L., Vozeh, S., Wenk, M., Weiss, P., and Follath, F. (1989), “Population Pharmacokinetics of Tobramycin,” British Journal of Clinical Pharmacology, 28, 305-314.
2. Beal, S. L., and Sheiner, L. (1982), “Estimating Population Kinetics,” CRC Critical Reviews in Biomedical Engineering, 8, 195-222.
3. Beal, S. L., and Sheiner, L. (1985), “Methodology of Population Pharmacokinetics,” in Drug Fate and Metabolism, Vol. 5, eds. E. Garrett and J. H. Hirtz, New York: Marcel Dekker.
4. Beal, S. L., and Sheiner, L. (1988), “Heteroscedastic Nonlinear Regression,” Technometrics, 30, 327-338.
5. Bennett, J. E., and Wakefield, J. C. (1995), “The Bayesian Modelling of Covariates for Population Pharmacokinetic Models,” Under revision with the Journal of the American Statistical Association.
6. Chi, E. M., and Reinsel, G. C. (1989), “Models for Longitudinal Data With Random Effects and AR(1) Errors,” Journal of the American Statistical Association, 84, 452-459.
7. Clayton, D. G. (1991), “A Monte Carlo Method for Bayesian Inference in Frailty Models,” Biometrics, 47, 467-485.
8. Davidian, M., and Gallant, A. (1992), “Smooth Nonparametric Maximum Likelihood Estimation for Population Pharmacokinetics, With Applica-tion to Quinidine,” Journal of Pharmacokinetics and Biopharmaceutics, 20, 529-556.
9. Davidian, M., and Gallant, A. (1993), “The Nonlinear Mixed Effects Model With a Smooth Random Effects Density,” Biometrika, 80, 475-488.
10. Davidian, M., and Goltinan, D. M. (1995), Nonlinear Models for Repeated Measurement Data. Chapman and Hall.
11. Dempster, A. P., and Ryan, L. M. (1985), “Weighted Normal Plots,” Journal of the American Statistical Association, 80, 845-850.
12. Fattinger, K., Vozeh, S., Ha, H., Borner, M., and Follath, F. (1991), “Population Pharmacokinetics of Quinidine,” British Journal of Clinical Phar-macology, 31, 279-286.
13. Gelfand, A. E., Dey, D. K., and Chang, H. (1992), “Model Determination Using Predictive Distributions, With Implementation via Sampling- Based Methods,” in Bayesian Statistics 4, eds. J. M. Bernardo et al., London: Oxford University Press.
14. Gelfand, A. E., Hills, S. E., Racine-Poon, A., and Smith, A. F. M. (1990), “Illustration of Bayesian Inference in Normal Data Models Using Gibbs Sampling,” Journal of the American Statistical Association, 85,972-985.
15. Gelman, A., and Rubin, D. (1993), “Inferences From Iterative Simulation Using Multiple Sequences,” Statistical Science, 7, 457-472.
16. Geyer, C. (1993), “Practical Markov Chain Monte Carlo,” Statistical Science, 7, 473-483.
17. Gibaldi, M., and Perrier, D. (1982), Drugs and the Pharmaceutical Sciences, Vol. 15: Pharmacokinetics (2nd ed.) New York: Marcel Dekker.
18. Gilks, W. R., Best, N. G., and Tan, K. K. C. (1995), “Adaptive Rejection Metropolis Sampling Within Gibbs Sampling,” Applied Statistics, 44, 455-472.
19. Hastings, W. K. (1970), “Monte Carlo Sampling-Based Methods Using Markov Chains and Their Applications,” Biometrika, 57, 97-109.
20. Lange, N., Carlin, B. P., and Gelfand, A. E. (1992), “Hierarchical Bayes Models for the Progression of HIV Infection Using Longitudinal CD+ Counts,” Journal of the American Statistical Association, 87, 615-625.
21. Lange, N., and Ryan, L. (1989), “Assessing Normality in Random Effects Models,” The Annals of Statistics, 17, 624-642.
22. Lindstrom, M. I., and Bates, D. M. (1990), “Nonlinear Mixed Effects Models for Repeated Measures Data,” Biometrics, 46, 673-687.
23. Maitre, P. O., Buhrer, M., Thomson, D., and Stanski, D. (1991), “A Three-Step Approach to Combining Bayesian Regression and NONMEM Pop-ulation Analysis: Application to Midazolam,” Journal of Pharmacokinetics and Biopharmaceutics, 19, 377-384.
24. Mallet, A. (1986), “A Maximum Likelihood Estimation Method for Random Coefficient Regression Models,” Biometrika, 73, 645-656.
25. Mallet, A. (1992), “A Nonparametric Method for Population Pharmacokinetics: A Case Study,” in American Statistical Association Proceedings of the Biopharmaceutical Section, pp. 11-20.
26. Mallet, A., Mentre, F., Steimer, J.-L., and Lokiec, F. (1988), “Nonparametric Maximum Likelihood Estimation for Population Pharmacokinetics, With Application to Cyclosporine,” Journal of Pharmacokinetics and Biopharmaceutics, 16, 311-327.
27. Mandema, J. W., Verotta, D., and Sheiner, L. (1992), “Building Population Pharmacokinetic Models-Pharmacodynamic Models for Covariate Effects,” Journal of Pharmacokinetics and Biopharmaceutics, 20, 511-528.
28. Ochs, H., Greenblatt, D. J., and Woo, E. (1980), “Clinical Pharmacokinetics of Quinidine,” Clinical Pharmacokinetics, 5, 150-168.
29. Racine, A. (1992), “SAGA: Sample Assisted Graphical Analysis,” in Bayesian Statistics 4, eds. J. M. Bernardo et al., London: Oxford University Press.
30. Racine, A., Grieve, A. P., Fluhler, H., and Smith, A. F. M. (1986), “Bayesian Methods in Practice: Experiences in the Pharmaceutical Industry” (with discussion), Applied Statistics, 35, 93-150.
31. Racine-Poon, A. (1985), “A Bayesian Approach to Non-Linear Random Effects Models,” Biometrics, 41, 1015-1024.
32. Schumitzky, A. (1991), “Nonparametric EM Algorithms for Estimating Prior Distributions,” Applied Mathematics and Computation, 45, 141-157.
33. Sheiner, L., Rosenberg, B., and Melmon, K. L. (1972), “Modelling of Individual Pharmacokinetics for Computer-Aided Drug Dosage,” Computers and Biomedical Research, 5, 441-459.
34. Smith, A. F. M., Skene, A. M., Shaw, J. E. H., Naylor, J. C., and Dransfield, M. (1985), “The Implementation of the Bayesian Paradigm,” Communications in Statistics, Theory and Methods, 14, 1079-1102.
35. Steimer, J.-L., Mallet, A., Golmard, J., and Boisieux, J. (1985), “Alternative Approaches to Estimation of Population Pharmacokinetic Parameters: Comparison With the Nonlinear Mixed Effect Model,” Drug Metabolism Reviews, 15, 265-292.
36. Steimer, J.-L., Vozeh, S., Racine-Poon, A., Holford, N. G., and O'Neill, R. (1994), “The Population Approach: Rationale, Methods, and Applications in Clinical Pharmacology and Drug Development, in Handbook of Experimental Pharmacology, Volume 110, Pharmacokinetics of Drugs, eds. P. Welling and H. Balant, New York: Springer-Verlag.
37. Tierney, L. (1994), “Markov Chains for Exploring Posterior Distributions,” The Annals of Statistics, 22, 1701-1762.
38. Verme, C. N., Ludden, T. M., Clementi, W. A., and Harris, S. C. (1992), “Pharmacokinetics of Quinidine in Male Patients,” Clinical Pharma-cokinetics, 22, 468-480.
39. Vonesh, E. F., and Carter, R. L. (1992), “Mixed-Effects Nonlinear Regression for Unbalanced Repeated Measures,” Biometrics, 48, 1-17.
40. Wakefield, J. C. (1993), Contribution to Discussion on “The Gibbs Sampler and Other Markov Chain Monte Carlo Methods,” Journal of the Royal Statistical Association, 55, 3-102.
41. Wakefield, J. C. (1994), “An Accepted Loss Approach to the Design of Dosage Regimens via Sampling-Based Methods,” The Statistician, 43, 13-29.
42. Wakefield, J. C., and Racine-Poon, A. (1995), “An Application of Bayesian Population Pharmacokinetic/Pharamcodynamic Models to Dose Rec-ommendation,” Statistics in Medicine, 14, 971-986.
43. Wakefield, J. C., Smith, A. F. M., Racine-Poon, A., and Gelfand, A. E. (1994), “Bayesian Analysis of Linear and Nonlinear Population Models Using the Gibbs Sampler,” Applied Statistics, 43, 201-221.
44. Walker, S. G., and Wakefield, J. C. (1994), “Population Models with a Non-Parametric Random Coefficient Distribution,” under revision with Scandanavian Journal of Statistics.
45. Whiting, B., Kelman, A. W., and Grevel, J. (1986), “Population Pharmacokinetics. Theory and Clinical Application,” Clinical Pharmacokinetics, 11, 387-401.
46. Zeger, S. L., and Karim, M. (1991), “Generalized Linear Models With Random Effects; A Gibbs Sampling Approach, Journal of the American Statistical Association, 86, 79-86.